ATLASIntensity Therapeutics (INTS) earnings date: Nov 5, 2026
Intensity Therapeutics (INTS) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 5, 2026, before the open. Analysts expect EPS of -$0.94.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on INTS
| Last price | $3.47 (+2.1%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.8% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Intensity Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Intensity Therapeutics reports on Nov 5, 2026. One email the day before, with ATLAS’s read on Intensity Therapeutics. You can switch it off at any time.
Alert me before INTS reportsFree to start. Creating an account takes under a minute.
Notify me when Intensity Therapeutics reports
Track INTS free Add Intensity Therapeutics to a free ATLAS watchlist and see its next report date in one place.
INTS earnings at a glance
| Next report (confirmed) | Thu, Nov 5, 2026 |
|---|---|
| Time | Before the open |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.94 |
| Last report | Aug 11, 2026 · Miss |
| Beat rate (last 4 reports) | 2 of 4 (50%) |
| Average EPS surprise | +2.0% |
| Average move around a report | ±4.4% (last 4) |
| Sector | Healthcare · Biotechnology |
Intensity Therapeutics earnings history: last 4 reports
Intensity Therapeutics last reported on Aug 11, 2026: EPS of -$1.11 against an estimate of -$0.77 (-44.2% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 11, 2026 | -$0.77 | -$1.11 | -44.2% | Miss | -3.0% |
| Jul 30, 2026 | $0.20 | $0.29 | +45.0% | Beat | -4.2% |
| May 7, 2026 | -$1.09 | -$0.96 | +11.9% | Beat | -2.3% |
| Nov 4, 2025 | $3.16 | $3.01 | -4.7% | Miss | -8.1% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for INTS
See the fair value, the probability range and the earnings history of Intensity Therapeutics on its ATLAS page.
Intensity Therapeutics (INTS) stock analysisPlans from €3.99 a month.
Intensity Therapeutics earnings: frequently asked questions
When does Intensity Therapeutics (INTS) report earnings?
Intensity Therapeutics is scheduled to report on Thursday, November 5, 2026, before the open. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for INTS?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.94 per share (USD). Estimates can change before the report.
How often does INTS beat earnings estimates?
Of its last 4 reports with a recorded result, Intensity Therapeutics beat the EPS estimate 2 times; the average surprise was +2.0%. Past results do not predict the next one.
How much does INTS move around earnings?
Over its last 4 reports the stock moved an average of 4.4% (absolute, from the close before the report day to the close after it), and finished higher 0 of 4 times.
Did Intensity Therapeutics beat earnings estimates last quarter?
Intensity Therapeutics last reported on Aug 11, 2026: EPS of -$1.11 against an estimate of -$0.77 (-44.2% surprise), a miss.
How much does INTS usually move in a day?
On a normal trading day the ATLAS model puts INTS’s one-day range at about ±3.8%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 5, 2026
Educational information, not investment advice. Disclaimer